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Abstract Enoyl-ACP reductase, a component of fatty acid
synthase, is a target for anti-microbial agents and herbicides.
Here we demonstrate the kinetic mechanism to be a compulsory-
order ternary complex with NADH binding before the acyl
substrate. Matrix-assisted laser desorption ionisation mass
spectrometry analysis of enzymatically and synthesised croto-
nyl-ACP substrate showed the former to contain a single acyl
group, whereas the latter contained up to four additional
crotonylations. The use of authentic crotonyl-ACP will be im-
portant in future kinetic and crystallographic studies. ß 2000
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
The synthesis of fatty acids in plants and most prokaryotes
is carried out by a series of soluble enzymes, each of which
encodes a single catalytic activity. During fatty acid biosyn-
thesis, the growing carbon chain is attached to acyl carrier
protein (ACP); the carbon chain is elongated by repeated
condensation of a two-carbon unit from the donor malonyl-
ACP. The resulting L-keto group is sequentially reduced to a
hydroxyl, enoyl and methylene group before a further con-
densation reaction takes place.
Enoyl-ACP reductase (ENR), which catalyses the NADH-
speci¢c reduction of a trans carbon^carbon double bond to
produce saturated acyl-ACP has been puri¢ed from spinach
leaves [1], avocado mesocarp [2] and Brassica napus seeds [3].
There has been extensive interest in ENR from both plant and
bacterial sources as a potential target for development of new
anti-microbial agents and herbicides. ENR is a target for iso-
niazid inhibition of the growth of Mycobacterium tuberculosis,
the causative agent of tuberculosis [4,5], as well as the action
of diazaborines that inhibit the growth of Escherichia coli
[6,7]. The three dimensional (3D) structures of the ENR
from B. napus [8], M. tuberculosis [9] and E. coli [10] have
all been determined. Additionally it has been shown that the
mode of action of the broad anti-microbial agent triclosan, a
widely used additive in the detergent industry, is speci¢cally
directed at ENR [11,12]. Despite the solution of the 3D struc-
ture of ENR, and its importance as a target for rational drug
design, no analysis has been performed on the kinetic mech-
anism of the enzyme.
The natural substrate for B. napus ENR is enoyl-ACP; the
enzyme will also use enoyl-coenzyme A (CoA) derivatives as
substrate analogues, but with higher Km values. Crotonyl-
CoA (cro-CoA) has most often been used in studies with
this enzyme, as it is readily available commercially.
Here we report that use of the substrate analogue cro-CoA,
in kinetic experiments, and crotonyl-ACP (cro-ACP), in sub-
strate binding experiments, to investigate the kinetic mecha-
nism of ENR. Enzymatically synthesised cro-ACP is shown to
contain a single crotonyl substitution, whereas chemically syn-
thesised cro-ACP contains up to four additional crotonyl
groups. The use of authentic substrate will be important in
future ENR^substrate co-crystallisation trials.
2. Materials and methods
2.1. ENR assay
The standard assay for detection of ENR activity contained 10 mM
sodium phosphate bu¡er (pH 6.2), 120 WM cro-CoA, 140 WM NADH
and a suitable amount of enzyme; the initial velocity of NADH ox-
idation was recorded at 340 nm. Assays carried out to determine the
order of binding contained various concentrations of cofactor and
substrate as described under Section 3.
2.2. Synthesis of analysis of ACPs
Recombinant E. coli apo-ACP was produced from a pET11d-based
expression plasmid containing a 600 bp E. coli genomic DNA insert
which includes the open reading frame for E. coli ACP (gift of A.R.
Stuitje). Cro-ACP was synthesised by direct crotonyl-phosphopante-
theine transfer from cro-CoA to apo-ACP catalysed by holo-ACP
synthetase, or by chemical modi¢cation of holo-ACP puri¢ed from
E. coli [13]. The enzymatic reaction contained 50 mM potassium
phosphate bu¡er, 333 WM apo-ACP, 666 WM cro-CoA, 2 mM
EDTA, 10 mM MgCl2, 3.3 WM holo-ACP synthase (pH 7.3) [14].
The reaction was carried out for 3 h at 37‡C, bu¡er exchanged using
a PD10 column (Pharmacia) equilibrated in milli Q water and the
product eluted in the same prior to freeze-drying and storage at
380‡C.
The identity of ACPs was con¢rmed and quanti¢ed by visualisation
of the mobility on 18% native polyacrylamide gels containing 0.5 M
urea [15]. Matrix-assisted laser desorption ionisation (MALDI-TOF)
mass spectrometry analyses of ACP and cro-ACP were carried out
using a Voyager DE-STR BioSpectrometry workstation (PerSeptive
Biosystems, Framingham, MA, USA) in linear positive ion mode
with delayed extraction. The samples were diluted in 50% acetonitrile,
0.1% tri£uoroacetic acid to a ¢nal concentration of approximately
1.0 pmol/Wl and then loaded together (1:1) with a 3,5-dimethoxy-4-
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hydroxycinnamic acid (Sigma) matrix (10 Wg/Wl in 50% acetonitrile,
0.1% tri£uoroacetic acid) directly onto a sample grid. The grid was
allowed to air dry before being loaded into the mass spectrometer. A
laser intensity of 2500 was used to obtain optimum resolution of the
ACP spectra and a low mass gate of 4000 m/z was applied to suppress
interference from matrix ion peaks. A calibration mixture containing
bovine insulin (5734.59 Da), E. coli thioredoxin (11 674.48 Da), and
horse myoglobin (16 952.56 Da) was used to determine masses.
2.3. Ultra¢ltration binding assays
Assays were carried out to assess the binding of each substrate to
the enzyme in the absence of the other substrate. Ultrafree-MC 30 000
NMWL centrifugal micro-concentrators (Millipore, UK) were used to
retain the enzyme, and any bound substrate molecules, above a 30
kDa cut-o¡ ¢lter. Duplicate assays were arranged so that substrate
was mixed with pure protein, above the ¢lter, in a molar ratio of
1 ENR tetramer (400 pmol):10 substrate (4 nmol). The enzyme^sub-
strate mixture was allowed to equilibrate for 10 min at room temper-
ature prior to ¢ltration, which was carried out in a centrifuge at
5000Ug for 10 min at 20‡C. The quantity of substrate present in
the ¢ltrate was determined from molar extinction coe⁄cients. The
molar extinction coe⁄cient of trans-2-unsaturated thioesters is
6.7U103 M31 m31 at 263 nm [1] and that of NADH is 6.22U103
M31 cm31.
3. Results and discussion
3.1. Characterisation of recombinant plant ENR
B. napus ENR was expressed in E. coli BL21 (DE3) from
the T7-based plasmid pEAR2 [16] and puri¢ed essentially by
the procedure used to isolate the enzyme from rape seed [3].
During cloning procedures used to introduce plant ENR
cDNA into the E. coli expression vector, the N-terminal ami-
no acid sequence was changed from SESSES to MAESSES
[16]. Protein sequence analysis of the expressed recombinant
protein revealed the sequence AESSES, indicating removal of
the initiating formyl-methionine residue.
Fig. 1. Determination of kinetic mechanism as sequential or substi-
tution. Assays were carried out using varying cro-CoA concentra-
tions at ¢xed, non-saturating concentrations of NADH (3.44 WM
(E), 9.09 WM (7), and 14.20 WM (a)). Assays were performed in
triplicate and data analysed by linear regression; the family of lines
produced on the double reciprocal plot converged, indicating a se-
quential mechanism.
Fig. 2. Product inhibitor studies to determine the order of substrate binding. Assays were performed using varying concentrations of one sub-
strate at ¢xed, non-saturating concentrations of the second substrate in the absence of product (E) and in the presence of 0.5 mM (O) and 1.0
mM (a) product. Double reciprocal plots using: (A) varying NADH concentrations at 120 WM cro-CoA and di¡erent ¢xed concentrations of
NAD ; (B) varying NADH concentrations at 120 WM cro-CoA and di¡erent ¢xed concentrations of butyryl-CoA; (C) varying cro-CoA con-
centrations at 10 WM NADH and di¡erent ¢xed concentrations of NAD ; (D) varying cro-CoA concentrations at 10 WM NADH and di¡erent
¢xed concentrations of butyryl-CoA.
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ENR puri¢ed from developing rape seed had apparent Km
values of 7.6 WM for NADH and 178 WM for cro-CoA [3]; the
recombinant protein showed similar Michaelis constants of
9.5 WM for NADH and 253 WM for cro-CoA when assayed
under identical conditions. Analysis of the recombinant en-
zyme revealed a subunit mass of approximately 32 kDa on
SDS^PAGE and a native molecular mass of 130 kDa by gel
¢ltration. These criteria indicate that the plant ENR cDNA is
expressed in E. coli and the puri¢ed protein is correctly as-
sembled and fully functional (data not shown).
The enzyme was able to reduce cro-ACP, cro-CoA and
decenoyl-CoA with NADH as cofactor, but was unable to
act on any of these substrates in the presence of NADPH.
These data con¢rm that the B. napus cDNA encodes an
NADH-speci¢c ENR and in this respect it is unlike the
E. coli enzyme that is able to utilise both NADH and
NADPH as cofactor [17].
3.2. Molar extinction coe⁄cient for ENR
Comparison of amino acid analysis data with the known
amino acid sequence of ENR, deduced from the cDNA,
showed that the analysis was accurate to þ 6% for the amino
acids: glycine, arginine, phenylalanine, leucine and lysine
which are not subject to modi¢cations during analysis [18].
The same preparation of recombinant ENR was also used
to determine the spectral properties of the enzyme. Data
from these two experiments were used to calculate the molar
extinction coe⁄cient at 278 nm of 2.95U105 M31 cm31.
3.3. Stabilisation of the catalytic activity of diluted enzyme
It was necessary to carry out enzyme assays over an ex-
tended period of time, using the same dilution of enzyme;
therefore conditions were sought to minimise time-dependent
changes in catalytic activity. Dilution in 37.5 mM sodium
phosphate, 1 mg/ml bovine serum albumin (BSA), 1 mM di-
thiothreitol, 1 mM EDTA and 20% w/v glycerol (pH 6.2),
maintained full activity over a 5 h period; 98% of the activity,
present immediately after dilution, was observed more than
24 h later. The presence of BSA did not reduce the concen-
tration of cro-CoA in the assay mixture, as determined by
initial velocity measurements of freshly prepared enzyme di-
lutions in the presence and absence of BSA.
3.4. Determination of reaction mechanism; sequential or
substitution?
An investigation to di¡erentiate between sequential and
substitution reaction mechanisms was carried out using cro-
CoA as a substrate analogue. In a series of assays using ¢xed,
non-saturating levels of NADH (3.44 WM, 9.09 WM and 14.20
WM) and varying concentrations of cro-CoA (100^500 WM),
the family of lines produced on a double reciprocal plot con-
verged (Fig. 1). A similar converging pattern of lines was
observed when ¢xed, non-saturating levels of cro-CoA and
varying NADH concentrations were employed (data not
show). These patterns are characteristic of a sequential or
ternary complex reaction mechanism.
3.5. Product inhibition studies
The products of the ENR reaction, butyryl-CoA and
NAD, were utilised as inhibitors in order to determine
whether the reaction proceeded via a random or compul-
sory-order ternary-complex mechanism using the rules of Cle-
land [19]. Analysis of the results in the form of double recip-
rocal plots indicated competitive inhibition when NADH was
varied in the presence of NAD (Fig. 2A). When NADH was
varied in the presence of butyryl-CoA (Fig. 2B), cro-CoA
varied in the presence of NAD (Fig. 2C) and cro-CoA varied
in the presence of butyryl-CoA (Fig. 2D), mixed patterns of
inhibition were observed. This combination of inhibition pat-
terns is indicative of a compulsory-order ternary-complex
mechanism with NADH binding ¢rst.
3.6. Substrate binding assays
Evidence was sought to verify the reaction mechanism using
substrate binding assays and ACP substrates. The authenticity
of apo-ACP and enzymatically synthesised cro-ACP was veri-
¢ed by mass spectrometry (Fig. 3A,B) and visualisation on
18% native gels containing 0.5 M urea. The mass recorded
for cro-ACP of 8921 Da indicated the presence of a single
crotonyl group.
The cofactor, NADH, bound to ENR in a ratio of 1 mol of
enzyme to approximately 4 mol of NADH (1:3.6 and 1:4.3 in
duplicate assays). The native ENR enzyme is a tetramer with
each subunit having one NADH binding site, capable of bind-
ing NADH in the absence of the other substrate. This corre-
Fig. 3. MALDI-TOF mass spectrometry analysis of ACPs. (A) E.
coli apo-ACP, (B) enzymatically synthesised cro-ACP and (C)
chemically synthesised cro-ACP.
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lates with our results of product inhibition kinetic experiments
and also with crystallographic data [20].
There was no measurable interaction between cro-ACP and
ENR in substrate binding assays. Therefore we conclude that
cro-ACP does not bind to ENR in the absence of NADH and
con¢rms that the reaction mechanism must proceed via an
ordered ternary complex with NADH binding ¢rst. A model
has been proposed from recent crystallographic studies that
suggested the acyl chain of enoyl-ACP would lie above the
nicotinamide ring of the cofactor in the substrate binding site,
allowing the correct geometry for hydride attack of the enoyl
substrate [21]. Such a model would require the NADH cofac-
tor to be bound to the enzyme before the enoyl substrate.
Similarly, there was no interaction between apo-ACP and
ENR, indicating no interactions occur between amino acids
of the enzyme and the carrier protein in the absence of
NADH.
3.7. Implications for future studies
Cro-CoA is a convenient substrate analogue for measure-
ment of enzyme activity. However, crystals of ENR grown in
the presence of cro-CoA showed binding at the site where the
adenine ring and associated ribose of NADH bind in an
ENR^NAD binary complex [20]. Therefore cro-CoA has lim-
ited utility in ENR^acyl substrate co-crystals and future work
will require the use of the true ACP-based substrates.
Previous syntheses of cro-ACP have largely been conducted
using holo-ACP, puri¢ed from E. coli, chemically modi¢ed
with crotonic anhydride [13]. Fig. 3C shows a MALDI-TOF
spectrum of chemically crotonylated E. coli ACP. The peak at
8510 Da is apo-ACP (a minor component of the starting
material), which does not contain the phosphopantetheine
prosthetic group and therefore was not acylated to form
cro-ACP. Cro-ACP has a mass of 8921 Da and is the major
product of the reaction. Several additional peaks follow those
at 8510 Da and 8921 Da, with a periodicity of approximately
71 Da, indicating up to four additional crotonylations of the
carrier protein by this method. Cro-ACP synthesised chemi-
cally can be used as an assay substrate [13], but would com-
plicate attempts at structural determination of an ENR^cro-
ACP complex because of the additional crotonylations of the
carrier protein. Using the enzymatic synthesis described in this
work, crotonylation of the 4P phosphopantenthenyl thiol
group is uniquely and speci¢cally achieved (Fig. 3B). The
native substrate will be required for detailed kinetic and crys-
tallographic studies.
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